Clinical Trial Update: Efficacy and Safety Study of HRO350 in Patients with Mild-to-moderate Psoriasis (the 'HeROPA' Study). [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the efficacy and safety of HRO350 in mild-to-moderate psoriasis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• HRO350

Snippet

Sponsor: Arctic Bioscience | Conditions: Psoriasis | Phase 2 | Status: COMPLETED